ANIMUNE-Q
Live / Applied — New application — not yet assigned to an examiner (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 10 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99693605
- Mark type
- Stylized text
- Filed
- 10 Mar 2026
- Attorney of record
- Rodney L Skoglund
Goods and services
- Class 005 — Pharmaceuticals: Vaccine preparations; Vaccine adjuvants; Human vaccine preparations; Oral vaccine preparations; Adjuvants for medical purposes; Adjuvants for use with vaccines; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral diseases
Owner
- Q-VANT Biosciences, Inc., Forestdale, MA, US
Prosecution history
- 10 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Mar 2026 — NEW APPLICATION ENTERED
- 10 Mar 2026 — APPLICATION FILING RECEIPT MAILED